CAG repeats mimic CUG repeats in the misregulation of alternative splicing

被引:133
作者
Mykowska, Agnieszka [1 ]
Sobczak, Krzysztof [1 ]
Wojciechowska, Marzena [1 ]
Kozlowski, Piotr [1 ]
Krzyzosiak, Wlodzimierz J. [1 ]
机构
[1] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, PL-61704 Poznan, Poland
关键词
MYOTONIC-DYSTROPHY TYPE-1; INCLUSION-BODY FORMATION; RNA-BINDING PROTEIN; TRINUCLEOTIDE REPEAT; THERAPEUTIC STRATEGIES; MUSCLEBLIND PROTEINS; SKELETAL-MUSCLE; POLYGLUTAMINE DISEASES; PATHOGENIC MECHANISMS; MOLECULAR-MECHANISMS;
D O I
10.1093/nar/gkr608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutant transcripts containing expanded CUG repeats in the untranslated region are a pathogenic factor in myotonic dystrophy type 1 (DM1). The mutant RNA sequesters the muscleblind-like 1 (MBNL1) splicing factor and causes misregulation of the alternative splicing of multiple genes that are linked to clinical symptoms of the disease. In this study, we show that either long untranslated CAG repeat RNA or short synthetic CAG repeats induce splicing aberrations typical of DM1. Alternative splicing defects are also caused by translated CAG repeats in normal cells transfected with a mutant ATXN3 gene construct and in cells derived from spinocerebellar ataxia type 3 and Huntington's disease patients. Splicing misregulation is unlikely to be caused by traces of antisense transcripts with CUG repeats, and the possible trigger of this misregulation may be sequestration of the MBNL1 protein with nuclear RNA inclusions containing expanded CAG repeat transcripts. We propose that alternative splicing misregulation by mutant CAG repeats may contribute to the pathological features of polyglutamine disorders.
引用
收藏
页码:8938 / 8951
页数:14
相关论文
共 61 条
[1]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[2]   The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies [J].
Bauer, Peter O. ;
Nukina, Nobuyuki .
JOURNAL OF NEUROCHEMISTRY, 2009, 110 (06) :1737-1765
[3]   Neurodegeneration: RNA turns number one suspect in polyglutamine diseases [J].
Birman, Serge .
CURRENT BIOLOGY, 2008, 18 (15) :R659-R661
[4]   Huntington's disease:: from huntingtin function and dysfunction to therapeutic strategies [J].
Borrell-Pages, M. ;
Zala, D. ;
Humbert, S. ;
Saudou, F. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (22) :2642-2660
[5]  
BROOK, 1992, CELL, V69, P385
[6]   SCA1 TRANSGENIC MICE - A MODEL FOR NEURODEGENERATION CAUSED BY AN EXPANDED CAG TRINUCLEOTIDE REPEAT [J].
BURRIGHT, EN ;
CLARK, HB ;
SERVADIO, A ;
MATILLA, T ;
FEDDERSEN, RM ;
YUNIS, WS ;
DUVICK, LA ;
ZOGHBI, HY ;
ORR, HT .
CELL, 1995, 82 (06) :937-948
[7]   Repeat instability as the basis for human diseases and as a potential target for therapy [J].
Castel, Arturo Lopez ;
Cleary, John D. ;
Pearson, Christopher E. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (03) :165-170
[8]   Fourteen and counting: unraveling trinucleotide repeat diseases [J].
Cummings, CJ ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2000, 9 (06) :909-916
[9]   RNA Gain-of-Function in Spinocerebellar Ataxia Type 8 [J].
Daughters, Randy S. ;
Tuttle, Daniel L. ;
Gao, Wangcai ;
Ikeda, Yoshio ;
Moseley, Melinda L. ;
Ebner, Timothy J. ;
Swanson, Maurice S. ;
Ranum, Laura P. W. .
PLOS GENETICS, 2009, 5 (08)
[10]   Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation [J].
Davies, SW ;
Turmaine, M ;
Cozens, BA ;
DiFiglia, M ;
Sharp, AH ;
Ross, CA ;
Scherzinger, E ;
Wanker, EE ;
Mangiarini, L ;
Bates, GP .
CELL, 1997, 90 (03) :537-548